Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Investments:
Fixed maturities available-for-sale, at fair value (amortized cost: $148.5 million and $127.3 million, respectively)	$ 141.5	$ 121.1
Short-term investments, at fair value (amortized cost: $188.6 million and $325.6 million, respectively)	188.5	324.8
Total investments	330.0	445.9
Cash and cash equivalents	228.4	194.5
Restricted cash	41.0	50.0
Accounts receivable, net of allowance of $0.4 million and $0.3 million, respectively	145.4	107.2
Reinsurance recoverable on paid and unpaid losses and LAE	297.3	286.3
Prepaid reinsurance premiums	375.5	309.9
Ceding commissions receivable	79.9	45.8
Capitalized internal use software	46.9	38.8
Intangible assets	23.6	26.9
Other assets	79.0	63.6
Total assets	1,647.0	1,568.9
Liabilities:
Loss and loss adjustment expense reserve	359.9	293.8
Unearned premiums	441.8	341.3
Reinsurance premiums payable	291.1	207.1
Provision for commission	18.0	5.0
Accrued expenses and other liabilities	124.9	128.2
Total liabilities	1,235.7	975.4
Commitments and contingencies (Note 12)
Stockholders’ equity:
Common stock, $0.0001 par value per share; 80,000,000 and 80,000,000 shares authorized as of September 30, 2023 and December 31, 2022, respectively; 23,891,930 and 23,201,434 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	0.0	0.0
Additional paid-in capital	1,606.1	1,558.0
Accumulated other comprehensive loss	(7.1)	(7.0)
Accumulated deficit	(1,192.0)	(961.1)
Total Hippo stockholders’ equity	407.0	589.9
Noncontrolling interest	4.3	3.6
Total stockholders’ equity	411.3	593.5
Total liabilities and stockholders’ equity	$ 1,647.0	$ 1,568.9